DLA Piper advises board on IPO of LEG Immobilien AG
DLA Piper has been advising the reconstituted supervisory board of LEG Immobilien AG in connection with the change in legal form and stock market flotation of LEG Immobilien AG on matters of equity and capital market law.
LEG Immobilien AG has commenced its listing on the regulated market (Prime Standard) of the Frankfurt Stock Exchange. In consideration of the over-allotment 30.453.980 shares were issued overall.
The issue price was €44 per share. So the placement volume is about €1.2bn resp. €1.3bn in the case of completely exerted greenshoe option.
The bank consortium consisted of the global coordinators and joint bookrunners Goldman Sachs and Deutsche Bank, as well as the co-lead managers Berenberg, Commerzbank, Erste Group Bank and Kempen & Co. The LEG shares were offered publicly to private investors in Germany and Luxembourg, as well as to institutional investors in Germany and abroad by private placement.
The LEG Group with some 91,000 housing units is one of the largest residential property companies in Germany. The company is in an attractive business field in the economically strong market of North-Rhine Westphalia and is striving to acquire selected portfolios or real estate companies in order to continue consistently implementing its growth strategy.
The team from DLA Piper included the partners Kerstin Schnabel and Dr Andreas Meyer-Landrut (both Corporate, Equity, Cologne) as well as Eyke Grüning (Finance & Projects, Capital Markets, Frankfurt am Main). They were supported by counsel Dr Christian Schneider (Insurance, Cologne) together with the associates Dr Cornelia Wendel and Bettina Haider (both Corporate, Equity, Cologne).
News from DLA Piper
T Steven Har joins DLA Piper's litigation practice in New York
Ugo de Vivo joins DLA Piper's finance and projects team in London
Who's Who Legal names DLA Piper as 2013's top international franchise law firm
DLA Piper receives international franchise accolade for ninth consecutive year
DLA Piper acts for Bothar Boring & Tunnelling in Austrialian LNG investment
Briefings from DLA Piper
What Supreme Court’s Myriad decision means for biopharma companies
On 13 June 2013, the US Supreme Court ruled that certain patent claims owned by US biotech company Myriad Genetics are invalid as products of nature.
Obama moves to curb patent trolls — but beware of unintended consequences
President Obama has announced a new initiative aimed at curbing patent infringement suits by ‘patent trolls’ who generate revenue through extortionate litigation.
Analysis from The Lawyer
Charge of the lit brigade
The Lawyer’s latest Top 50 litigation firms list shows that business for dispute specialists is roaring along while new in-depth detail reveals the winning strategies
International firms
With a glut of UK firms being taken over by global giants, the international table has been reconfigured, with a better than ever showing for one-stop-shoppers.
